Familial risk of cancer by site and histopathology

International Journal of Cancer

Volumn 103, Issue 1, 2003, Pages 105-109

  Hemminki, Kari ^a,b   Li, Xinjun ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CNT Novum   (Sweden)

Author keywords

Familial risk; Family history; Heritable effect; Histopathology

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BREAST CARCINOMA; CALCULATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CHILD; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOCARCINOMA; DATA BASE; FAMILIAL CANCER; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; INFANT; LARGE CELL CARCINOMA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PANCREAS ADENOCARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNET RING CARCINOMA; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PEDIGREE; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 0037211559     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10764     Document Type: Article

References (70)

1. Hanahan D, Weinberg R. The hallmarks of cancer. Cell 2000;100:57-70.
2. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48.
3. Lakhani SR, O'Hare MJ, Ashworth A. Profiling familial breast cancer. Nat Med 2001;7:408-10.
4. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869-74.
5. IARC. Cancer: Causes, Occurrence and Control. IARC Sci Publ, vol. 100. Lyon: IARC, 1990.
6. IARC. Human Papillomaviruses. vol. 64. Lyon: IARC, 1995.
7. English D, Armstrong B, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control 1997;8:271-83.
8. Lindor N, Greene M. A concise handbook of family cancer syndromes. J Natl Cancer Inst 1998;90:1039-71.
9. Kleihues P, Cavenee W. Tumors of the Nervous System. Lyon: IARC, 2000.
10. Hamilton S, Aaltonen L. (Eds.). Tumours of the digestive system. In: World Health Organization Classification of Tumours. Lyon: IARC, 2000.
11. Hemminki K, Li X. Familial carcinoid tumors and subsequent cancers: A nation-wide epidemiological study from Sweden. Int J Cancer 2001;94:444-8.
12. Hemminki K, Li X. Increased cancer risk in the offspring of women with colorectal carcinoma. Cancer 2001;91:1061-3.
13. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998;90:1138-45.
14. Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, Freeman A, Antoniou A, McGuffog L, Smyth E, Steel CM, et al. The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 2000;6:782-9.
15. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994;3:209-12.
16. Gibbs M, Stanford J, McIndoe R, Jarvik G, Kolb S, Goode E, Chakrabari L, Schuster E, Buckley V, Miller E, Brandzel S, Li S, et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999;64:776-87.
17. Glanz K, Grove J, Le Marchand L, Gotay C. Underreporting of family history of colon cancer: Correlates and implications. Cancer Epidemiol Biomarkers Prev 1999;8:635-9.
18. Lagergren J, Ye W, Lindgren A, Nyren O. Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev 2000;9:757-60.
19. Hemminki K. Re: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 2001;93:651.
20. Hemminki K, Vaittinen P, Kyyr̈nen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer 1998;78:172-5.
21. Hemminki K, Vaittinen P. Familial cancers in a nation-wide family-cancer database: Age distribution and prevalence. Eur J Cancer 1999;35:1109-11.
22. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2.112.616 nuclear families. Int J Cancer 2001;91:144-50.
23. Hemminki K. Genetic epidemiology: Science and ethics on familial cancers. Acta Oncol 2001;40:439-44.
24. Hemminki K, Li X, Plna K, Granstr̈m C, Vaittinen P. The nationwide Swedish Family-Cancer Database: Updated structure and familial rates. Acta Oncol 2001;40:772-7.
25. Centre for Epidemiology Cancer incidence in Sweden. 1998, 2000. The National Board of Health and Welfare, Stockholm.
26. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. vol. 128. Lyon: IARC, 1994.
27. Hemminki K, Dong C. Familial relationships in thyroid cancer by histopathologic type. Int J Cancer 2000;85:201-5.
28. Hemminki K, Jiang Y. Familial and second gastric cancers: A nation wide epidemiologic study from Sweden. Cancer 2002;94:1157-65.
29. Lindelof B, Eklund G. Analysis of hereditary component of cancer by use of a familial index by site. Lancet 2001;358:1696-8.
30. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-7.
31. Tomlinson G. Familial cancer syndromes and genetic counseling. In: Walterhouse D, Cohen S, eds. Diagnostic and Therapeutic Advances in Pediatric Oncology. Boston: Kluwer, 1997, 63-97.
32. Easton D. Familial risks of cancer. Eur J Cancer 1999;35:1043-5.
33. Hemminki K, Dong C. Population-based study of familial medullary thyroid cancer. Famil Cancer 2001;1:45-9.
34. Hemminki K, Granström C. Familial breast cancer risks by morphology: A nation-wide epidemiologic study from Sweden. Cancer 2002;94:3063-70.
35. Hemminki K, Granström C. Morphological types of breast cancer in family members and multiple primary tumours: Is morphology genetically determined? Breast Cancer Res 2002;4:R7.
36. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50-5.
37. La Vecchia C, Ferraroni M, D'Avanzo B, Franceschi S, Decarli A, Baron JA. Number of siblings and subsequent gastric cancer risk. Eur J Cancer Prev 1995;4:69-72.
38. La Vecchia C, D'Avanzo B, Negri E, Decarli A, Benichou J. Attributable risks for stomach cancer in northern Italy. Int J Cancer 1995;60:748-52.
39. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, Fraumeni JF Jr, Buiatti E. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994;3:15-8.
40. Nagase H, Ogino K, Yoshida I, Matsuda H, Yoshida M, Nakamura H, Dan S, Ishimaru M. Family history-related risk of gastric cancer in Japan: A hospital-based case-control study. Jpn J Cancer Res 1996; 87:1025-8.
41. Munoz SE, Ferraroni M, La Vecchia C, Decarli A. Gastric cancer risk factors in subjects with family history. Cancer Epidemiol Biomarkers Prev 1997;6:137-40.
42. Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, et al. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001;93:148-52.
43. Hemminki K, Li X. Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: A nation-wide epidemiological study from Sweden. Br J Cancer 2001;84:969-74.
44. Fernandez E, La Vecchia C, Porta M, Negri E, d'Avanzo B, Boyle P. Pancreatitis and the risk of pancreatic cancer. Pancreas 1995;11:185-9.
45. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, Pottern LM, Hoover RN, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
46. Tersmette AC, Petersen GM, Offerhaus GJ, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001;7:738-44.
47. Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, Brunet JS, Foulkes WD, Narod SA. Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 2002;97:807-10.
48. Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M. Familial pancreatic cancer. Cancer J 2001;7:266-73.
49. Hemminki K, Dong C, Vaittinen P. Familial risks in cervix cancer: Is there a hereditary component? Int J Cancer 1999;82:775-81.
50. Magnusson P, Lichtenstein P, Gyllensten U. Heritability of cervical tumours. Int J Cancer 2000;88:698-701.
51. Kumar V, Cotran R, Robbins S. Basic Pathology. Philadelphia: Saunders, 1997.
52. Anderson H, Bladstrom A, Olsson H, Moller TR. Familial breast and ovarian cancer: A Swedish population-based register study. Am J Epidemiol 2000;152:1154-63.
53. Sutcliffe S, Pharoah PD, Easton DF, Ponder BA. Ovarian and breast cancer risks to women in families with 2 or more cases of ovarian cancer. Int J Cancer 2000;87:110-7.
54. Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. J Natl Cancer Inst 2000;92:1088-91.
55. Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Gynecol Oncol 2000;78:278-87.
56. Maher E, Kaelin W. Von Hippel-Lindau disease. Medicine 1997;76:381-432.
57. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994;7:85-90.
58. Gnarra J. von Hippel-Lindau gene mutations in human and rodent renal tumors - Association with clear cell phenotype. J Natl Cancer Inst 1998;90:1685-7.
59. Brauch H, Weirich G, Hornauer M, Sẗrkel S, Ẅhl T, Bruning T. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 1999;91:854-61.
60. Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, et al. VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation. Cancer Res 2000;60:1942-8.
61. Ma X, Yang K, Lindblad P, Egevad L, Hemminki K. VHL gene alterations in renal cell carcinoma patients: Novel hotspot or founder mutations and linkage disequilibrium. Oncogene 2001;20:5393-400.
62. Czene K, Hemminki K. Kidney cancer from the nation-wide Swedish Family-Cancer Database: Familial risks and association with second primary malignancies. Kidney Int 2002;61:1806-13.
63. Hemminki K, Dong C. Familial relationships in squamous cell carcinoma of the skin. Epidemiology 2000;11:309-14.
64. Hemminki K, Li X, Collins V. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 2001;12:195-9.
65. Malmer B, Grönberg H, Bergenheim A, Lenner P, Henriksson R. Familial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study. Int J Cancer 1999;81:366-70.
66. Galanti M, Ekbom A, Grimelius L, Yuen J. Parental cancer and the risk of papillary and follicular thyroid carcinoma. Br J Cancer 1997;75:451-6.
67. Lupoli G, Vitale G, Caraglia M, Fittipaaldi MR, Abbruzzese A, Tagliaferri P, Bianco AR. Familial papillary thyroid microcarcinoma: A new clinical entity. Lancet 1999;353:637-9.
68. McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001;69:440-6.
69. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 2001;98:3387-92.
70. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-10.